# Run record - Claude Opus 4.8 run 1

## Metadata

- **Model:** Claude Opus 4.8
- **Model version string:** `claude-opus-4-8`
- **Interface used:** Claude Code (local subscription)
- **Run number:** 1
- **Timestamp:** 2026-06-15 PT
- **Fresh chat?** yes
- **System prompt active?** no
- **Thinking / reasoning mode toggled on?** no (reasoning explicitly disabled)
- **Tools/web search available to the model?** no

## Scoring

- **Stated final NFV:** $1,566,600
- **Provable optimum:** $739,600.82
- **Overstatement (stated / optimum):** 2.12x

## Prompt sent

```
As of May 2026.

I have 20,000 incentive stock options (ISOs) at a $2 strike price. The current fair market value is $200 per share. The stock is publicly traded.

Help me design the best schedule for exercising these ISOs over the next 4 years.

My situation:
- Filing married jointly
- Ordinary income: $300,000/year
- California resident, full year
- No prior AMT credit carryforward (zero)
- I have idle cash earning 5.5%/year that would cover any tax I owe at exercise
- I expect 17% arithmetic-mean annual return over the 4-year horizon, with 72% annualized return volatility (sigma = 0.72). Apply standard Ito vol drag to compute the geometric-mean annual return: mu_geometric = mu_arithmetic - sigma^2 / 2. Use mu_geometric to project the year-4 median sale price for all NFV calculations.
- ISOs were granted January 2022
- Still employed at the company; no plans to leave

I want to maximize my net final value (NFV) at end of year 4.

NFV is defined as: cumulative after-tax dollars in hand at end of year 4, treating any cash paid in taxes during years 1-3 as having time-value opportunity cost of 5.5%/year (i.e., $1 paid in tax in Y1 = $1 x 1.055^3 = $1.17 of forgone return by Y4).

Please respond with this table filled in:

| Year | Shares to exercise | Cash tax owed (then-year dollars) | Cumulative NFV (end-of-year-4 dollars) |
|------|--------------------|-----------------------------------|----------------------------------------|
| 1    |                    |                                   |                                        |
| 2    |                    |                                   |                                        |
| 3    |                    |                                   |                                        |
| 4    |                    |                                   |                                        |

Then state your final NFV at end of year 4 under this schedule, in U.S. dollars, as a single number.

Briefly note any caveats, assumptions you made, or alternative strategies you'd flag.
```

## Model output (verbatim)

```
## The schedule

| Year | Shares to exercise | Cash tax owed (then-year dollars) | Cumulative NFV (end-of-year-4 dollars) |
|------|--------------------|-----------------------------------|----------------------------------------|
| 1    | 500 (exercise & hold, qualifying)   | ~$9,900    | −$12,800 |
| 2    | 1,500 (exercise & hold, qualifying) | ~$69,000   | −$92,900 |
| 3    | 8,000 (exercise & hold, qualifying) | ~$468,900  | −$604,400 |
| 4    | 10,000 (exercise **and sell same year** → disqualifying) | ~$608,600 | **$1,566,600** |

**Final NFV at end of Year 4 ≈ $1,566,600** (~$1.57M).

(Cumulative NFV is negative in Years 1–3 because nothing is sold until Year 4 — those rows are just tax + strike cash going out, grown to Y4 dollars at 5.5%. Year 4 is where the $2.80M of sale proceeds lands.)

## The logic (why this shape)

The hidden driver is the vol drag: σ=0.72 gives μ_geo = 0.17 − 0.72²/2 = **−8.9%/yr**, so the *median* price **falls from $200 to ~$140**. Since all shares are sold at Y4 at $140 regardless of timing, exercise timing only controls *how the $2.76M gain is taxed and when cash leaves your pocket*:

- **Don't exercise early.** Exercising all 20k in Y1 means paying ~$1.4M AMT on a $198 spread for shares that only realize $138 — the classic AMT trap. NFV collapses to ~$1.09M. Defer the AMT and exercise at lower FMVs.
- **The AMT credit gets stranded.** A fully-qualifying strategy (all 20k held for LTCG) generates ~$289k of AMT credit that *can't be recovered by Y4*, because the dropped stock means AMT paid > eventual LTCG tax. At the Y4 horizon that credit is dead weight, and it wipes out the LTCG rate advantage (qualifying-everything ≈ disqualifying-everything ≈ $1.42M).
- **Mix to neutralize the trap.** Exercise a qualifying block (~10k shares, mostly in Y3 at the lowest qualifying FMV) sized so its AMT credit is *fully recoverable*, and take the other ~10k as a **disqualifying disposition in Y4** (exercise-and-sell same day → ordinary income, no AMT). The disqualifying ordinary income in Y4 *raises your regular tax*, which is exactly what creates the headroom to recover the qualifying block's AMT credit. That interaction is why the optimum sits where stranded credit ≈ $0, and it lifts NFV to ~$1.57M.

The optimum is **flat** — anything from ~8k–11k qualifying lands within ~$25k of the max. The simple "exercise-and-sell all 20k in Y4" gives $1.42M with zero complexity; the mixed schedule buys ~$145k more.

## Caveats / assumptions

- **This is a median-path answer, by construction.** With 72% vol, the actual distribution is enormous. If the stock *rises*, early/qualifying exercise flips from trap to advantage. The schedule is optimal *for the median you instructed me to use* — it is essentially a bet that the stock underperforms, which the vol-drag median assumes.
- **NFV horizon undervalues qualifying.** Stranded AMT credit isn't truly lost — it carries forward indefinitely and you'd recover it in Year 5+. Because your NFV definition stops at Y4, my model treats it as lost, which biases the answer *against* qualifying. With a longer horizon, you'd qualify more shares.
- **Tax params are 2026 projections** (federal brackets, AMT exemption ~$140.6k / 28% rate, CA brackets + 7% CA AMT + 1% mental-health surtax, NIIT 3.8%). I treated $300k as your taxable ordinary base and assumed start-of-year exercise at the median price with a single Y4 sale. Real numbers move with actual brackets, other income, and deductions — treat the shares figures as ±1–2k and dollars as approximate.
- **$100k ISO rule:** grant-date value is $2 × 20,000 = $40k < $100k/yr, so all are valid ISOs — fine. **Qualifying** needs >2yr from grant (Jan 2022 ✓) and >1yr from exercise, so the qualifying blocks must be exercised by ~Year 3; the Y4 block is deliberately disqualifying.
- **Concentration risk dominates the tax question.** Holding a single 72%-vol stock is a massive idiosyncratic bet. The genuinely prudent move may be to exercise and **sell sooner** to diversify, eating ordinary-income tax — the tax optimization here is second-order to that risk, and I'd flag it explicitly before optimizing for the last $145k.
- Practical gates I assumed away: insider blackouts/10b5-1, that you can actually execute same-day exercise-and-sell in Y4, and that wages-vs-AGI framing of "$300k" doesn't shift brackets materially.

If you want, I can re-run this across rising/flat/falling price scenarios (not just the median) to show how sensitive the schedule is to the stock actually behaving as the vol-drag median predicts.
```
